Catalyst Update
Historically (through Edgar filings) BioPharmX 10k reporting came out April 21, 2017.
Possible 10k this month April Fri. 20
Phase IIb results were released the first week of May in 2017.
Look for BioPharmX most recent data the first week of May 2018
Partnership/Funding News
has been expected as well
As stated on BioPharmX Facebook page, BioPharmX must stay above $0.20, 30 days prior to June 1st for NYSE compliance.
Expectations of positive news to lift the stock price well above the $0.20 requirement throughout the month of May
From a charts perspective, the MA(50) is $0.03 away from crossing over the MA(200).
"Golden Cross", considered a bullish sign!
